Greece
• 20 years at Johnson & Johnson, worked in Pharma, Medical Devices, and Consumer sectors • Strategic & Operational experience in Marketing, Sales, and Market Access in Global, Regional (EMEA), and Country leadership roles • Proven track record of delivering business growth and exceeding goals even in highly competitive and challenging environments • Recognized for developing talent, building high-performing cross-functional teams, and transforming culture • Agility, strategic thinking, creativity, strong influencing and leadership skills • Passion for mentoring and coaching young women leaders in pharma
• Full P&L accountability for the entire portfolio of J&J medicines (hematology, oncology, immunology, neuroscience, rare diseases). • Leading the commercial group of 52 employees (sales, marketing, and business development/ distributor management), achieving exceptional sales growth of 11% above business plan targets and 25% YoY growth for the promoted brands. • The Greek team recognized for Europe's most successful launches of new oncology & hematology medicines, awarded for multiple best practices. • Revamped the commercial organization by upscaling sales & marketing capabilities, increasing customer focus & operational excellence, optimizing structure & governance, and simplifying processes. • Transformed the team's culture with empowering purpose-driven leadership, focusing on open dialogue, recognition, and inclusion, reflected in record-high J&J Leader survey results. • Built a strong talent pipeline - developed team with coaching, training programs, and GROW assignments, moves to EMEA & other functions, promotions. Selected to mentor German talents. • Exceptional growth for the distributor markets (Cyprus, Malta, and Greece) with strategic re-focus. • Member of the Greek Leadership Team.
• Oversaw commercial, medical, market access & policy strategies’ development & execution at a cluster level, for 10 countries across Central Europe & Baltics, for the hematology (oncology) portfolio (60% of the business). • Led a team of 11 managers, including Marketing, Medical, Digital, Market Access, and Government Affairs. • Upscaled local capabilities by optimizing sales messaging, training, storytelling & assertive selling, driving >30% sales growth. • Championed the evolution of medical education, introducing a regionally aligned KOL engagement plan, physicians’ experience-sharing forums, and centers of excellence, resulting in high customer satisfaction metrics as per IQVIA research. • Proactively led the region’s first policy-shaping and innovative access initiatives (Myeloma Awareness Campaign and Outcomes-Based Reimbursement), enhancing enterprise-wide impact on patient access in Central Europe, earning an INSPIRE award. • Strengthened talent pipeline through promotion to and import from big-5 EU countries, GROW assignments, mentorships. • Member of the Central Europe & Baltics Leadership Team, influenced Country Managers to adopt a more competitive mindset.
• Led global commercialization strategy for J&J’s COVID-19 vaccine, including competitive positioning, messaging, omnichannel patient & HCP education, and global public health stakeholder engagement. High visibility to Senior Leadership. • Developed the US public education strategy and direct-to-consumer digital awareness campaign, that increased vaccine confidence. Partnered with trade & advocacy groups, health authorities, pharmacies, insurers, and public-private partnerships. • Awarded for demonstrating agile mindset and rapid cross-functional mobilization under pressure (Supply Chain, R&D, Access, Medical, Public Health, Adv. Agency), contributing to one of the most high-stakes public health launches in company history.
• Led global strategy and brand management for ACUVUE® OASYS® ($800M in sales), increasing global market share, by developing new sales messaging, competitive claims, sales training, and publication strategy. • Collaborated with EMEA, US, APAC and LATAM, aligning messaging and go-to-market approaches to maximize regional growth. • Led a cross-functional team to reposition ACUVUE® portfolio ($3B in sales) by aligning it with patient needs, resulting in 8% sales growth. Influenced senior leadership and acted as a change agent for both the organization (new way of portfolio selling, innovation roadmap) and the marketplace (brand decision based on patient needs, elevating role of eye care professional). • Developed a new global creative and campaign for eye care professionals that elevated the brand equity in the US.
• Achieved a 2ppt market share increase for OASYS® in EMEA by developing new professional messaging and campaign, ensuring alignment and optimal execution across EMEA, which became a standard of excellence for the region. • Received a Leadership Award for transforming ACUVUE® professional communication, changing the sales messaging focus from technical features to patient outcomes, which created a best practice adopted globally.
• Led cross-functional teams to re-launch the flagship RoC® product line, developing a 3-year innovation strategy, including product and claims pipeline, as well as communication strategy with TV, print, and digital campaigns.
• Pharmacy Channel • Drove >10% sales growth and launched multiple new products, managing P&L, forecasting, and budgeting.